Based on the entirety of our experimental results, we propose a model whereby the treatment of NPC cells with NEO212 causes increased ROS levels, which cause ER stress and induction of CHOP, resulting in the activation of EBV’s lytic cycle. The gene discussed is DDIT3; the disease is nasopharyngeal carcinoma.